ADAPT Algorithm for Cardiac Event Risk
A simplified model to indicate the risk of a major adverse coronary event (MACE)

Clinical indication
The Calculator is intended to be used for patients presenting to the Emergency Department with Chest Pain aged 18 years or older.
Research authors: Martin Than, Louise Cullen, Sally Aldous, William A. Parsonage, Christopher M. Reid, Jaimi Greenslade, Dylan Flaws, Christopher J. Hammett, Daren M. Beam, Michael W. Ardagh, Richard Troughton, Anthony F. T. Brown, Peter George, Christopher M. Florkowski, Jeffrey A. Kline, Frank Peacock, Alan S. Maisel, Swee Han Lim, Arvin Lamanna, A. Mark Richards
Version: 2.2
V-2.2-158.23.10.09
(01)08719327522721(8012)v2.2(4326)231009(240)158
  • Details
  • Intended purpose
  • Electronic label
  • Release Notes

Calculate the result

Set more parameters to perform the calculation

30-day risk of MACE is %

{{ resultSubheader }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

It should be noted that, while the ADAPT can be used with contemporary cardiac troponin assays, it performs better with high-sensitivity cardiac troponin assays (hs-cTn), especially for the Fairly Low Risk category.

In the derivation study of Than et al. (2012) using contemporary (not high-sensitivity) troponin assays (Abbott ARCHITECT cTnI assay and DxI Access Accu cTnI assay)
Low Risk: 1 out of 392 patients had a Major Adverse Cardiac Event within 30 days (0.26% risk)
Fairly Low Risk: 8 out of 367 patients had a Major Adverse Cardiac Event within 30 days (2.18% risk)
High Risk: 293 out of 1216 patients had a Major Adverse Cardiac Event within 30 days (24.1% risk)

In a Validation study by Cullen et al. (2013) using the ARCHITECT High Sensitive STAT Troponin-I assay
Low Risk: 0 out of 550 patients had a Major Adverse Cardiac Event within 30 days (0% risk)
Fairly Low Risk: 3 out of 479 patients had a Major Adverse Cardiac Event within 30 days (0.63% risk)
High Risk: 400 out of 1515 patients had a Major Adverse Cardiac Event within 30 days (26.4% risk)

A pooled analysis of multiple studies containing 3163 patients with a total of 487 events found a sensitivity of 99.79% and a negative predictive value of 99.86% for the Low Risk category

A pooled analysis of multiple studies exclusively using hs-cTn assays containing 4021 patients with a total of 646 events found a sensitivity of 99.23% and a negative predictive value of 99.68% for the combined categories of Low Risk and Fairly Low Risk.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

Underlying models Part of
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}


Evidencio Community Account Benefits


With an Evidencio Community account you can:

  • Create and publish your own prediction models.
  • Share your prediction models with your colleagues, research group, organization or the world.
  • Review and provide feedback on models that have been shared with you.
  • Validate your models and validate models from other users.
  • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction models and their data.
  • Use patient specific protocols and guidelines based on sequential models and decision trees.
  • Stay up-to-date with new models in your field as they are published.
  • Create your own lists of favorite models and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.


Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Evidencio v3.25 © 2015 - 2024 Evidencio. All Rights Reserved